UK Respiratory Drug Market Size | COVID-19 Impact Analysis | Forecast to 2025

UK respiratory drug market was $11.1 billion in 2018 and is anticipated to grow at a substantial rate of 7.0% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the respiratory drug market in Europe. Respiratory drugs are used for treatment of patient from asthma attacks and other respiratory ailments. As the prevalence of asthma and other diseases increases across UK, the demand of respiratory drugs is also expected to increase for treatment purposes. As per International Monetary Fund GDP of the country was $2.9 trillion in 2017. UK comprises of England, Scotland, Wales and Northern Ireland. Total population of the country in 2017 was 65 million, out of which about 18% are of geriatric population. Mortalities related to asthma and COPD are high in UK and due to these a significant investment by government and people can be forecast in the near future.

To Request a Sample of our Report on UK Respiratory Drug Market: https://www.omrglobal.com/request-sample/uk-respiratory-drug-market

The UK respiratory drug market is segmented on the basis of route of administration, application, and end-user. Based on the route of administration, the market is classified into oral, injectable, and inhalable. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. The asthma disease application segment dominated the regional market in 2018 and is further estimated to follow the same trend over the forecast period. This is mainly due to the high prevalence of asthma in the nation. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

(Get 15% Discount on Buying this Report)

A full Report of UK Respiratory Drug Market is Available @ https://www.omrglobal.com/industry-reports/uk-respiratory-drug-market

UK Respiratory Drug Market Segmentation

By Route of Administration

· Oral

· Injectable

· Inhalable

· France Respiratory Drug Market by Application

· Asthma

· Chronic Obstructive Pulmonary Disease (COPD)

By End-User

· Homecare

· Hospitals and Clinics

Company Profiles

· Air Liquide S.A.

· Aradigm Corp.

· AstraZeneca PLC

· Baxter International Inc.

· Boehringer Ingelheim International GmbH

· F. Hoffmann-La Roche Ltd.

· GlaxoSmithKline PLC

· Merck & Co.

· Novartis AG

· Omron Healthcare Inc.

· Pfizer Inc.

· Pulmatrix Inc.

· ResMed Corp.

· Savara, Inc.

· Sunovion Pharmaceuticals

· Takeda Pharmaceutical Company Ltd.

· Teva Pharmaceuticals Industries Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.